Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure

Annals of Pharmacotherapy

Volumn 42, Issue 6, 2008, Pages 888-892

  Bos Thompson, Marie Andrée ^a   Hillaire Buys, Dominique ^a   Roux, Clarisse ^a   Faillie, Jean Luc ^a   Amram, Daniel ^b  

^a LAPEYRONIE HOSPITAL   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Fetal ischemia; Mifepristone; Misoprostol; M bius syndrome; Pregnancy

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADULT; ARTICLE; CASE REPORT; CHEMICAL TERATOGENESIS; ECHOGRAPHY; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; GENETIC COUNSELING; HUMAN; JAW MALFORMATION; MALE; METRORRHAGIA; MICRORETROGNATHIA; MOEBIUS SYNDROME; MUSCLE HYPOTONIA; NEWBORN; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADULT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MIFEPRISTONE; MISOPROSTOL; MOBIUS SYNDROME; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 44649147211     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K550     Document Type: Article

References (26)

1. Vidal 2007. Le Dictionnaire. 83 e édition. Maury-Imprimeur SA, Malesherbes (France) 1er trimestre 2007.
2. Golberg AB, Greenberg BS, Damey PD. Misoprostol and pregnancy. N Engl J Med 2001;344:38-47.
3. Gonzalez CH, Marques-Dias MJ, Kim CA, et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998;351:1624-7.
4. Marques-Dias MI, Gonzalez CH, Rosemberg S. Möbius sequence in children exposed in utero to misoprostol: neuropathological study of three cases. Birth Defects Research (Part A) 2003;67:1002-7.
5. Sanchez O, Guerra D. Moebius syndrome due to the use of misoprostol. Case report. Invest Clin 2003;44:147-53.
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
7. Abramson DL, Cohen MM, Mulliken JB. Möbius syndrome: classification and grading system. Plast Reconstr Surg 1998;102:961-7.
8. Strömland K, Sjögreen L, Miller M, et al. Möbius sequence - a Swedish multidiscipline study. Eur J Paediatr Neurol 2002;6:35-45.
9. Issaivanan M, Virdi VS, Parmar VR. Subclavian artery supply disruption sequence - Klippel-Feil and Möbius anomalies. Indian J Pediatr 2002; 69:441-2.
10. Bavinck JN, Weaver DD. Subclavian artery supply disruption sequence: hypothesis of a vascular etiology for Poland, Klippel-Feil, and Möbius anomalies. Am J Med Genet 1986;23:903-18.
11. D'Cruz OF, Swisher CN, Jaradeh S, Tang T, Konkol RJ. Möbius syndrome: evidence for a vascular etiology. J Child Neurol 1993;8:260-5.
12. Dooley JM, Stewart WA, Hayden JD, Therrien A. Brainstem calcification in Möbius syndrome. Pediatr Neurol 2004;30:39-41.
13. St Charles S, Dimario FJ, Grunnet ML. Möbius sequence: further in vivo support for the subclavian artery supply disruption sequence. Am J Med Genet 1993;47:289-93.
14. Homes LB. Teratogen-induced limb defects. Am J Med Genet 2002;112: 297-303.
15. Allen BM, Wert MA, Tatum SA. Congenital unilateral multiple cranial neuropathy: an etiology shared with Möbius syndrome? Int J Pediatr Otorhinolaryngol 2006;70:931-4.
16. Shepard TH. Möbius syndrome after misoprostol: a possible teratogenic mechanism. Lancet 1995;346:780.
17. Pastuszak AL, Schüler L, Speck-Martins CE, et al. Use of misoprostol during pregnancy and Möbius' syndrome in infants. N Eng J Med 1998; 338:1881-5.
18. da Silva Dal Pizzol T, Knop FP, Mengue SS. Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis. Reprod Toxicol 2006;22:666-71.
19. Puvabanditsin S, Garrow E, Augustin G, Titapiwatanakul R, Kuniyoshi K. Poland-Möbius syndrome and cocaïne abuse: a retook at vascular etiology. Pediatr Neurol 2005;32:285-7.
20. Graf WD, Shepard TH. Uterine contractions in the development of Möbius syndrome. J Child Neurol 1997;12:225-6.
21. Gonzalez CH, Vargas FR, Alvarez Perez AB, et al. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993;47:59-64.
22. Vargas FR, Schuler-Faccini L, Brunoni D, et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 2000;95:302-6.
23. Lim BH, Lees DAR, Bjomsson S, et al. Normal development after exposure to mifepristone in early pregnancy. Lancet 1990;336:257-8.
24. Pons JC, Imbert MC, Elefant E, et al. Development after exposure to mifepristone in early pregnancy (letter). Lancet 1991;338:763.
25. Yip SK, Tse AO, Haines CJ, Chung TK. Misoprostol's effect on uterine arterial blood flow and fetal heart rate in early pregnancy. Obstet Gynecol 2000;95:232-5.
26. Turan C, Koc N, Dansuk R, Cengizoglu B, Mericelli DS, Unal O. Misoprostol administration in first-trimester pregnancies with embryonic demise reduces uterine arterial blood flow. J Matern Fetal Neonatal Med 2003;14:226-8.